SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
Completed · Phase 3
Conditions studied: Hepatitis C
In brief
This study will assess the efficacy, safety, and tolerability of 16 or 24 weeks of sofosbuvir (Sovaldi®; SOF) + ribavirin (RBV), and 12 weeks of SOF+RBV+ pegylated interferon (Peg-IFN) in treatment-naive and treatment-experienced adults with chronic genotype 3 hepatitis C virus (HCV) infection, and treatment-experienced adults with cirrhosis and chronic genotype 2 HCV infection.
Key facts
- Study ID
- NCT01962441
- Run by
- Gilead Sciences
- People needed
- 601
- Starts
- 2013-09-24
- Expected to finish
- 2016-07-07
- Last updated by the study team
- 2017-06-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — San Diego, California, United States
- Study site — San Francisco, California, United States
- Study site — Aurora, Colorado, United States
- Study site — Englewood, Colorado, United States
- Study site — Miami, Florida, United States
- Study site — Wellington, Florida, United States
- Study site — Marietta, Georgia, United States
- Study site — New Orleans, Louisiana, United States
- Study site — Boston, Massachusetts, United States
- Study site — Novi, Michigan, United States
- Study site — Saint Paul, Minnesota, United States
- Study site — Hillsborough, New Jersey, United States
- Study site — Newark, New Jersey, United States
- Study site — Binghamton, New York, United States
- Study site — New York, New York, United States
- Study site — Germantown, Tennessee, United States
- Study site — Nashville, Tennessee, United States
- Study site — Nashville, Tennessee, United States
- Study site — Arlington, Texas, United States
- Study site — Austin, Texas, United States
- Study site — Norfolk, Virginia, United States
- Study site — Seattle, Washington, United States
- Study site — Camperdown, New South Wales, Australia
- Study site — Kogarah, New South Wales, Australia
- Study site — Riverside, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.